CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series

CA-125 has long been utilized as a surveillance biomarker for gynecologic malignancies but can be elevated in other conditions, including infection. A study of tumor markers in non-cancer patients saw a rise in CA-125 values during severe COVID-19 infections. Given the potential confounding effect t...

Descripción completa

Detalles Bibliográficos
Autores principales: Folsom, Susan M., Mumford, Brigid, Lemon, Lara, Taylor, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212932/
https://www.ncbi.nlm.nih.gov/pubmed/35747786
http://dx.doi.org/10.1016/j.gore.2022.101029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212932/
https://www.ncbi.nlm.nih.gov/pubmed/35747786
http://dx.doi.org/10.1016/j.gore.2022.101029

Ejemplares similares